PALLEIKO BENJAMIN L (CFO and Secretary) sold 0.7% of their position (3.32K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $88.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/13/2026ACC: 0001366244-26-000007
Officer· CFO and Secretary
Since Sep 2018
-3.32K
Net shares
Net seller
$88.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
7.12K acquired · 10.44K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.12K
Price / share
—
Trade value
—
% of position
1.5%
5/11/2026
462.58K→469.70K
Common Stock
Direct
Shares
−3.32K
Price / share
$26.71
Trade value
$88.73K
% of position
0.7%
5/12/2026
469.70K→466.38K
Total
Net shares
+3.80K
Net value
-$88.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/11/2026 | M · Option Exercise | +7.12K | — | — | 1.5% | 462.58K | 469.70K |
| Common Stock Direct | 5/12/2026 | S · Sale | −3.32K | $26.71 | $88.73K | 0.7% | 469.70K | 466.38K |
| Total | +3.80K | -$88.73K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
7.12K shares
Shares
−7.12K
Strike price
Held after
92.56K
Exercisable
—
5/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock7.12K shares | 5/11/2026 | M · Option Exercise | −7.12K | — | 92.56K |